I was doing some browsing online looking at the various clinical trials that are being conducted in the field of gynecology– specifically regarding vaginal atrophy symptoms. Vaginal atrophy, as you know from my other blogs, happens because of lowered levels of estrogen in the body due to natural menopause, surgical menopause, or during cancer treatments like chemotherapy. It causes physical changes to the vaginal tissues causing dryness, painful intercourse, vaginal itching and burning, and sometimes even urinary issues like increased frequency and irritation. Vaginal atrophy symptoms are a major complaint of menopausal women and lead to a reduced quality of life.
One listed clinical trial will test the effectiveness of a vaginal estrogen cream. One will test a vaginal suppository. Another will test a non-specific “investigational drug.” Another tries out a vaginal progesterone instead of estrogen. Another will test the sustainability of an ultra low-dose estrogen in post-menopausal women. And I think it’s great that we are thinking about ways to help women. Vaginal atrophy symptoms affect so many of our patients, and if we’re able to include more options for future treatment, that’s great.
However, many women cannot take hormones. Maybe they’re sensitive to hormone treatment. Maybe they’ve survived cancer and have been advised to avoid hormone replacement therapy. Whatever the reason, hormones are not the solution for everyone. That’s why we offer MonaLisa Touch, a vaginal rejuvenation treatment that actually heals the vagina. It doesn’t last forever and needs to be “touched up” about once a year, but it’s a non-hormonal, non-surgical, no-medication-needed treatment that brings significant relief to ladies with vaginal atrophy after the first treatment alone.
We are experiencing huge success with MonaLisa Touch Chico and want all women who suffer vaginal atrophy symptoms to know about it. If you can’t take hormones and have vaginal complaints, this might be the solution you’ve been looking for.
Clinical Trials Source: https://www.centerwatch.com/clinical-trials/listings/condition/639/vaginal-atrophy/